3 ms·
> The price of $3k for 8 doses is so high compared to regular ketamine. I wonder if there is any real difference or if you’re really just paying for the comfort
by loeg 8y ago
> The price of $3k for 8 doses is so high compared to regular ketamine. I wonder if there is any real difference or if you’re really just paying for the comfort of doing it legally under the guidance of a doctor.
You're really paying for the cost of bringing a new drug to market for a specific label use. It wouldn't be worth the multi-million dollar expense for any for-profit company to do the FDA process to show that ordinary ketamine is effective for depression, because they couldn't privatize the profits to recoup their costs.
Instead they make an arbitrary but likely nonfunctional[0] chemical change[1], get it approved, and use their patent to demand high costs to recoup their FDA process fees (and if they're lucky, to make a profit).
[0]: Edit/clarification: Apparently some (meta)studies suggest the S-isomer is better than the racemic mixtures in some ways (waving my hands; I did not read or understand the details).
[1]: Edit/clarification: I don't know enough chemistry to be sure if describing the extraction of the S-isomer from the racemic mixture is a "chemical change," exactly, but you get the idea.
- danmaz74 8y agoWe really really need some public body to pick up those cases. Or, at least, some non-profit. I'm sure many would contribute.
- loeg 8y agohttps://maps.org/ https://maps.org/ is basically running a crowd-funded FDA process for MDMA as a component of PTSD treatment. (Well, major funding came from one random bitcoin millionaire, but still.) The trouble for anyone (citizens, government, and biotech companies) is sifting the wheat from the chaff as far as what drugs are likely to be safe and effective treatments. You could give away all of your money and not end up with one approved drug.
- danmaz74 8y agoInteresting, thank you.